Cargando…

Cold agglutinin disease: current challenges and future prospects

Cold agglutinin disease (CAD) is a complement-dependent, classical pathway-mediated immune hemolytic disease, accounting for 15–25% of autoimmune hemolytic anemia, and at the same time, a distinct clonal B-cell lymphoproliferative disorder of the bone marrow. The disease burden is often high, but no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berentsen, Sigbjørn, Röth, Alexander, Randen, Ulla, Jilma, Bernd, Tjønnfjord, Geir E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497508/ https://www.ncbi.nlm.nih.gov/pubmed/31114413 http://dx.doi.org/10.2147/JBM.S177621

Ejemplares similares

Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy
por: Berentsen, Sigbjørn, et al.
Publicado: (2007)

Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?
por: Sefland, Øystein, et al.
Publicado: (2019)

Sutimlimab for the Treatment of Cold Agglutinin Disease
por: Berentsen, Sigbjørn
Publicado: (2023)

New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
por: Berentsen, Sigbjørn
Publicado: (2020)

Mortality in cold agglutinin disease shows seasonal pattern
por: Hansen, Dennis Lund, et al.
Publicado: (2022)

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
por: Röth, Alexander, et al.
Publicado: (2022)

Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results
por: Röth, Alexander, et al.
Publicado: (2022)

P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY
por: Röth, Alexander, et al.
Publicado: (2023)

Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease
por: Gelbenegger, Georg, et al.
Publicado: (2022)

P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
por: Röth, Alexander, et al.
Publicado: (2023)

Cold Agglutinin Disease; A Laboratory Challenge
por: Nikousefat, Zahra, et al.
Publicado: (2015)

Cold Agglutinin Disease
por: Gabbard, Amy P., et al.
Publicado: (2020)

P1486: SERUM BIOMARKERS AS PREDICTORS OF RESPONSE TO SUTIMLIMAB IN COLD AGGLUTININ DISEASE (CAD): A POST-HOC ANALYSIS OF PHASE 3 CARDINAL AND CADENZA STUDY DATA
por: Barcellini, Wilma, et al.
Publicado: (2023)

Pembrolizumab-Induced Cold Agglutinin Disease
por: Atiq, Osman, et al.
Publicado: (2020)

Necrosis secondary to cold agglutinin disease
por: Nakagawa, Hiroaki, et al.
Publicado: (2022)

P1538: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK WASHOUT PERIOD IN PHASE 3 CARDINAL STUDY (NCT03347396)
por: Röth, A., et al.
Publicado: (2022)

Tozinameran: Cold agglutinin disease: case report
Publicado: (2022)

A COLD CASE OF COVID-19-INDUCED COLD AGGLUTININ DISEASE
por: DOUEN, AARON, et al.
Publicado: (2021)

Acute exacerbation of cold agglutinin disease during operation
por: Jeong, Jinyoung, et al.
Publicado: (2013)

Cold agglutinin disease in sepsis: A rare entity
por: Garg, Ravinder, et al.
Publicado: (2015)

P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY
por: Röth, Alexander, et al.
Publicado: (2023)

COVID-19 and Cold Agglutinin Hemolytic Anemia
por: Maslov, Diana V., et al.
Publicado: (2020)

PB2549: CO-EXISTENT COLD AGGLUTININ DISEASE AND CRYOGLOBULINAEMIA
por: Japzon, Nicole, et al.
Publicado: (2023)

Cold Agglutinins and Cryoglobulins Associate With Clinical and Laboratory Parameters of Cold Urticaria
por: Bizjak, Mojca, et al.
Publicado: (2021)

Transient Cold Agglutinins in a Patient With COVID-19
por: Kaur, Jasmeet, et al.
Publicado: (2021)

Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report
por: Habberstad, Andreas Hanssønn, et al.
Publicado: (2018)

Two Cases of Primary Cold Agglutinin Disease Associated with Megaloblastic Anemia
por: Imashuku, Shinsaku, et al.
Publicado: (2015)

Glucocorticoid-Responsive Cold Agglutinin Disease in a Patient with Rheumatoid Arthritis
por: Honne, Kyoko, et al.
Publicado: (2015)

Cryoballoon Ablation Induced Hyperkalemia due to Possible Cold Agglutinin Disease
por: Kumanomido, Jun, et al.
Publicado: (2019)

Cold agglutinin disease and COVID-19 requiring therapeutic plasma exchange
por: Ahmed, Yousuf, et al.
Publicado: (2021)

Neutrophilic erythrophagocytosis in myelodysplastic syndrome and cold agglutinin disease co‐occurrence
por: Amelirad, Asra, et al.
Publicado: (2023)

Cold agglutinin disease: A case report with atypical clinical findings
por: Balaja, Warren, et al.
Publicado: (2023)

Role of Complement in Autoimmune Hemolytic Anemia
por: Berentsen, Sigbjørn
Publicado: (2015)

Cold Agglutinin Disease with Erythrophagocytosis by Neutrophils Occurring During Recovery Phase of Chickenpox
por: Walia, Harpreet, et al.
Publicado: (2013)

Recurrent Viral Infections Complicated with Cold Agglutinin Disease after Splenectomy for Thrombocytopenia
por: Shi, Hui-Ping, et al.
Publicado: (2018)

A novel method for demonstrating cold agglutinin disease: a case report
por: Vo, Thomas A., et al.
Publicado: (2018)

The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease
por: Zaninoni, Anna, et al.
Publicado: (2021)

SARS‐CoV‐2 infection complicated with cold agglutinin disease and myositis
por: Aldaghlawi, Fadi, et al.
Publicado: (2021)

Bilateral retinal vasculitis associated with cold agglutinin disease treated with obinutuzumab and infliximab
por: Than, Ngoc Trong Tuong, et al.
Publicado: (2022)

Hemolytic Anemia in the Setting of Atypical Pneumonia: A Case of Cold Agglutinin Disease
por: Jalal Eldin, Abdelwahab, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ilfa910vodtect3vtpis2fpr5v